NASDAQ:ALBO - Albireo Pharma SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$35.75 +0.14 (+0.39 %)
(As of 05/21/2019 04:00 PM ET)
Previous Close$35.61
Today's Range$35.38 - $36.69
52-Week Range$19.10 - $38.69
Volume50,400 shs
Average Volume45,012 shs
Market Capitalization$430.39 million
P/E RatioN/A
Dividend YieldN/A
Beta1.72

SEC Filings

Albireo Pharma (NASDAQ:ALBO) SEC Filings

DateFilerForm TypeView
05/09/2019
9:09 AM
Albireo Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/09/2019
6:47 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/01/2019
3:02 PM
Albireo Pharma (Filer)
Form 424B3
View Filing
04/30/2019
11:15 PM
Albireo Pharma (Filer)
Form EFFECT
View Filing
04/25/2019
3:05 PM
Albireo Pharma (Filer)
Form DEFA14A
View Filing
04/25/2019
3:03 PM
Albireo Pharma (Filer)
Form DEF 14A
View Filing
04/03/2019
5:02 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/27/2019
4:34 PM
Albireo Pharma (Issuer)
Stephenson Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/27/2019
4:29 PM
Albireo Pharma (Issuer)
Stephenson Pamela (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
03/13/2019
1:39 PM
Albireo Pharma (Subject)
Phase4 Partners Ltd (Filed by)
Form SC 13D/A
View Filing
03/07/2019
7:00 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/06/2019
4:28 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/06/2019
4:27 PM
Albireo Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
View Filing
03/06/2019
4:22 PM
Albireo Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/14/2019
6:53 AM
Albireo Pharma (Subject)
ArrowMark Colorado Holdings LLC (Filed by)
Form SC 13G
View Filing
02/13/2019
10:04 AM
Albireo Pharma (Subject)
Satter Muneer A (Filed by)
Form SC 13G/A
View Filing
01/24/2019
5:48 PM
Albireo Pharma (Issuer)
Horn Patrick Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/24/2019
5:45 PM
Albireo Pharma (Issuer)
Duncan Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/24/2019
5:28 PM
Albireo Pharma (Issuer)
Mattsson Jan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/24/2019
5:25 PM
Albireo Pharma (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/24/2019
5:21 PM
Albireo Pharma (Issuer)
Cooper Ronald Harold Wilfred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/24/2019
5:17 PM
Albireo Pharma (Issuer)
Carter Martha J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/15/2018
3:12 PM
Albireo Pharma (Issuer)
Cooper Ronald Harold Wilfred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/13/2018
6:16 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/08/2018
4:01 PM
Albireo Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
11/08/2018
3:14 PM
Albireo Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
10/12/2018
3:36 PM
Albireo Pharma (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/12/2018
3:28 PM
Albireo Pharma (Issuer)
Harford Simon N.R. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
10/10/2018
7:38 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/16/2018
3:26 PM
Albireo Pharma (Issuer)
Cooper Ronald Harold Wilfred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/09/2018
3:04 PM
Albireo Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
08/09/2018
2:06 PM
Albireo Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/08/2018
3:14 PM
Albireo Pharma (Issuer)
Horn Patrick Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/08/2018
3:09 PM
Albireo Pharma (Issuer)
Horn Patrick Taylor (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
08/07/2018
6:48 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/25/2018
7:39 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/06/2018
3:17 PM
Albireo Pharma (Issuer)
BROWN JULIA R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/18/2018
4:40 PM
Albireo Pharma (Issuer)
SCOON DAVEY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/18/2018
4:36 PM
Albireo Pharma (Issuer)
Okey Stephanie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/18/2018
4:33 PM
Albireo Pharma (Issuer)
Klibanski Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/18/2018
4:05 PM
Albireo Pharma (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/18/2018
4:02 PM
Albireo Pharma (Issuer)
Gutch Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/18/2018
3:58 PM
Albireo Pharma (Issuer)
Chiswell David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/14/2018
6:49 PM
Albireo Pharma (Issuer)
Mattsson Jan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/11/2018
3:37 PM
Albireo Pharma (Issuer)
Soni Paresh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/11/2018
3:26 PM
Albireo Pharma (Issuer)
Mattsson Jan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/11/2018
3:24 PM
Albireo Pharma (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/11/2018
3:22 PM
Albireo Pharma (Issuer)
Cooper Ronald Harold Wilfred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/11/2018
3:21 PM
Albireo Pharma (Issuer)
Carter Martha J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/11/2018
3:19 PM
Albireo Pharma (Issuer)
Okey Stephanie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/11/2018
3:18 PM
Albireo Pharma (Issuer)
Okey Stephanie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
06/11/2018
3:16 PM
Albireo Pharma (Issuer)
Klibanski Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/11/2018
3:14 PM
Albireo Pharma (Issuer)
Klibanski Anne (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
06/11/2018
3:12 PM
Albireo Pharma (Issuer)
Duncan Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/11/2018
3:09 PM
Albireo Pharma (Issuer)
Duncan Jason (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
06/11/2018
3:08 PM
Albireo Pharma (Issuer)
BROWN JULIA R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/11/2018
3:08 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/24/2018
3:09 PM
Albireo Pharma (Filer)
Form DEFA14A
View Filing
04/24/2018
3:06 PM
Albireo Pharma (Filer)
Form DEF 14A
View Filing
04/05/2018
2:18 PM
Albireo Pharma (Filer)
Form CT ORDER
View Filing
03/27/2018
1:45 PM
Albireo Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/19/2018
8:45 AM
Albireo Pharma (Filer)
Form NT 10-K
View Filing
03/15/2018
6:30 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/06/2018
3:30 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/15/2018
3:00 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/09/2018
3:04 PM
Albireo Pharma (Subject)
Satter Muneer A (Filed by)
Form SC 13G/A
View Filing
02/08/2018
3:55 PM
Albireo Pharma (Filer)
Form 424B5
View Filing
02/01/2018
3:48 PM
Albireo Pharma (Issuer)
Phase4 Partners Ltd (Reporting)
PHASE4 VENTURES III GENERAL PARTNER Ltd (Reporting)
PHASE4 VENTURES III LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/25/2018
4:25 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/25/2018
4:20 PM
Albireo Pharma (Filer)
Form 424B5
View Filing
01/25/2018
3:59 PM
Albireo Pharma (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/24/2018
3:19 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/24/2018
3:08 PM
Albireo Pharma (Filer)
Form 424B5
View Filing
12/18/2017
3:08 PM
Albireo Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
12/11/2017
11:54 AM
Albireo Pharma (Subject)
ASTRAZENECA PLC (Filed by)
Form SC 13D/A
View Filing
12/05/2017
11:15 PM
Albireo Pharma (Filer)
Form EFFECT
View Filing
12/05/2017
3:18 PM
Albireo Pharma (Issuer)
ASTRAZENECA AB (Reporting)
ASTRAZENECA PLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/04/2017
8:51 AM
Albireo Pharma (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
View Filing
12/04/2017
8:42 AM
Albireo Pharma (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
This page was last updated on 5/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel